Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03).

Gnant, M; Dueck, AC; Frantal, S; Martin, M; Burstein, HJ; Greil, R; Fox, P; Wolff, AC; Chan, A; Winer, EP; Pfeiler, G; Miller, KD; Colleoni, M; Suga, JM; Rubovsky, G; Bliss, JM; Mayer, IA; Singer, CF; Nowecki, Z; Hahn, O; Thomson, J; Wolmark, N; Amillano, K; Rugo, HS; Steger, GG; Hernando Fernández de Aránguiz, B; Haddad, TC; Perelló, A; Bellet, M; Fohler, H; Metzger Filho, O; Jallitsch-Halper, A; Solomon, K; Schurmans, C; Theall, KP; Lu, DR; Tenner, K; Fesl, C; DeMichele, A; Mayer, EL; J Clin Oncol. 2022; 40(3): 28-293.

DNA methylation profiles differ in responders versus non-responders to anti-PD-1 immune checkpoint inhibitors in patients with advanced and metastatic head and neck squamous cell carcinoma

Starzer, AM; Heller, G; Tomasich, E; Melchardt, T; Feldmann, K; Hatziioannou, T; Traint, S; Minichsdorfer, C; Schwarz-Nemec, U; Nackenhorst, M; Mullauer, L; Preusser, M; Berghoff, AS; Fuereder, T J IMMUNOTHER CANCER. 2022; 10(3): e003420

Persistence of ctDNA in Patients with Breast Cancer During Neoadjuvant Treatment Is a Significant Predictor of Poor Tumor Response.

Zhou, Q; Gampenrieder, SP; Frantal, S; Rinnerthaler, G; Singer, CF; Egle, D; Pfeiler, G; Bartsch, R; Wette, V; Pichler, A; Petru, E; Dubsky, PC; Bago-Horvath, Z; Fesl, C; Rudas, M; Ståhlberg, A; Graf, R; Weber, S; Dandachi, N; Filipits, M; Gnant, M; Balic, M; Heitzer, E; Clin Cancer Res. 2022; 28(4):697-707

Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma

Bishop, MR; Dickinson, M; Purtill, D; Barba, P; Santoro, A; Hamad, N; Kato, K; Sureda, A; Greil, R; Thieblemont, C; Morschhauser, F; Janz, M; Flinn, I; Rabitsch, W; Kwong, YL; Kersten, MJ; Minnema, MC; Holte, H; Chan, EHL; Martinez-Lopez, J; Muller, AMS; Maziarz, RT; McGuirk, JP; Bachy, E; Le Gouill, S; Dreyling, M; Harigae, H; Bond, D; Andreadis, C; McSweeney, P; Kharfan-Dabaja, M; Newsome, S; Degtyarev, E; Awasthi, R; del Corral, C; Andreola, G; Masood, A; Schuster, SJ; Jager, U; Borchmann, P; Westin, JR NEW ENGL J MED. 2022;

Kindlin-3 maintains marginal zone B cells but confines follicular B cell activation and differentiation

Harzschel, A; Li, LX; Krenn, PW; Szenes-Nagy, E; Andrieux, G; Bayer, E; Pfeifer, D; Polcik, L; Denk, U; Hopner, JP; Karabatak, E; Danner, DJ; Tangermann, S; Kenner, L; Jumaa, H; Greil, R; Borries, M; Ruppert, R; Maity, PC; Hartmann, TN J LEUKOCYTE BIOL. 2022;

Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma

Tilly, H; Morschhauser, F; Sehn, LH; Friedberg, JW; Trneny, M; Sharman, JP; Herbaux, C; Burke, JM; Matasar, M; Rai, S; Izutsu, K; Mehta-Shah, N; Oberic, L; Chauchet, A; Jurczak, W; Song, YQ; Greil, R; Mykhalska, L; Bergua-Burgues, JM; Cheung, MC; Pinto, A; Shin, HJ; Hapgood, G; Munhoz, E; Abrisqueta, P; Gau, JP; Hirata, J; Jiang, YW; Yan, M; Lee, C; Flowers, CR; Salles, G NEW ENGL J MED. 2022;

Disease-related blood-based differential methylation in cystic fibrosis and its representation in lung cancer revealed a regulatory locus in PKP3 in lung epithelial cells.

Schamschula, E; Lahnsteiner, A; Assenov, Y; Hagmann, W; Zaborsky, N; Wiederstein, M; Strobl, A; Stanke, F; Muley, T; Plass, C; Tummler, B; Risch, A Epigenetics. 2022; 17(8):837-860

Patterns of Thromboembolism in Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy with FOLFIRINOX or Gemcitabine/nab-Paclitaxel.

Riedl, JM; Schwarzenbacher, E; Moik, F; Horvath, L; Gantschnigg, A; Renneberg, F; Posch, F; Barth, DA; Stotz, M; Pichler, M; Hatzl, S; Fandler-Hofler, S; Gressenberger, P; Gary, T; Jost, PJ; Greil, R; Ay, C; Djanani, A; Gerger, A; Schlick, K Thromb Haemost. 2022; 122(4):633-645

Body composition dynamics and impact on clinical outcome in gastric and gastro-esophageal junction cancer patients undergoing perioperative chemotherapy with the FLOT protocol.

Huemer, F; Hecht, S; Scharinger, B; Schlintl, V; Rinnerthaler, G; Schlick, K; Heregger, R; Melchardt, T; Wimmer, A; Mühlbacher, I; Koch, OO; Neureiter, D; Klieser, E; Seyedinia, S; Beheshti, M; Greil, R; Weiss, L; J Cancer Res Clin Oncol. 2022;

Influence of HER2 expression on prognosis in metastatic triple-negative breast cancer-results from an international, multicenter analysis coordinated by the AGMT Study Group.

Gampenrieder, SP; Dezentjé, V; Lambertini, M; de Nonneville, A; Marhold, M; Le Du, F; Cortés Salgado, A; Alpuim Costa, D; Vaz Batista, M; Chic Ruché, N; Tinchon, C; Petzer, A; Blondeaux, E; Del Mastro, L; Targato, G; Bertucci, F; Gonçalves, A; Viret, F; Bartsch, R; Mannsbart, C; Deleuze, A; Robert, L; Saavedra Serrano, C; Gion Cortés, M; Sampaio-Alves, M; Vitorino, M; Pecen, L; Singer, C; Harbeck, N; Rinnerthaler, G; Greil, R; ESMO Open. 2022; 8(1): 100747